Clinical Trial

Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 27, 2018 (before its estimated June 18, 2019 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to examine critical aspects of radiation exposure, dose delivery, and systemic yttrium-90 (Y90) exposure related to the infusion of Y90 microspheres for treatment of hepatocellular carcinoma (HCC) and other metastatic liver disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2018-09-25.
Status change: Recruiting → Completed 2022-05-12
Trial Details
NCT Number NCT03686709
Lead Sponsor University of Tennessee
Collaborators: Biocompatibles UK Ltd
Conditions Hepatocellular Carcinoma, Radiation Exposure
Enrollment 20 participants
Start Date 2018-06-19
Primary Completion 2019-06-18 (estimated)
Study Completion 2019-12-31 (estimated)
Updated on ClinicalTrials.gov 2018-09-27